Cargando…

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia

PURPOSE: To evaluate the factors associated with the development of ocular candidiasis (OC) and ocular prognosis with echinocandin therapy for candidemia. METHODS: The medical records of 56 consecutive patients with a positive blood culture for Candida species between November 2016 and October 2019...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakai, Daiki, Matsumiya, Wataru, Kusuhara, Sentaro, Nakamura, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200333/ https://www.ncbi.nlm.nih.gov/pubmed/34121142 http://dx.doi.org/10.1186/s12348-021-00248-0

Ejemplares similares

The choroidal structure changes in a case with hypertensive choroidopathy
por: Sakai, Daiki, et al.
Publicado: (2020)

Ocular Candidiasis in Patients with Candidemia at a Large Tertiary Care Center
por: Lee, Bonny, et al.
Publicado: (2017)

146 Review of Empiric Echinocandin Therapy for Candidemia
por: Amado, Cristina, et al.
Publicado: (2014)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

1173. Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
por: White, Cameron, et al.
Publicado: (2020)

A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer
por: Kim, Kyung Woo, et al.
Publicado: (2021)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama, Atsuko, et al.
Publicado: (2019)

Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Risk factors and outcomes of patients with ocular involvement of candidemia
por: Son, Hyo-Ju, et al.
Publicado: (2019)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

2116. Comparative Effectiveness of Amphotericin B, Azoles, and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis: A Systematic Review and Network Meta-Analysis
por: Demir, Koray K, et al.
Publicado: (2019)

Impact of echinocandins as first-choice therapy in cardiothoracic high-risk patients with candidemia
por: Langebartels, G, et al.
Publicado: (2013)

A case of probable Vogt–Koyanagi–Harada disease in a 3-year-old girl
por: Katsuyama, Atsuko, et al.
Publicado: (2019)

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
por: Kusuhara, Sentaro, et al.
Publicado: (2023)

468. Assessment of The Proportion of Hospitalized Patients (Pts) with Candidemia (C) and Invasive Candidiasis without Candidemia (IC) Who Received an Echinocandin (EC) and Were Potentially Eligible for an Earlier Hospital Discharge (HD)
por: Lodise, Thomas, et al.
Publicado: (2022)

Risk Factors and Clinical Characteristics of Patients with Ocular Candidiasis
por: Sakamoto, Toru, et al.
Publicado: (2022)

The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
por: De Rosa, Francesco G., et al.
Publicado: (2015)

Outcomes of Primary 27-Gauge Vitrectomy for 73 Consecutive Cases With Uveitis-Associated Vitreoretinal Disorders
por: Kim, Kyung Woo, et al.
Publicado: (2021)

Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination
por: Yasuda, Eriko, et al.
Publicado: (2022)

Correction: The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
Publicado: (2015)

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
por: Lausch, Karen Rokkedal, et al.
Publicado: (2018)

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
por: Kishi, Maya, et al.
Publicado: (2023)

Usefulness of intraoperative optical coherence tomography to minimize the intraocular lens tilt during the intrascleral fixation: a clinical and experimental evaluation
por: Sotani, Yasuyuki, et al.
Publicado: (2023)

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
por: Chubachi-Kamimura, Aya, et al.
Publicado: (2023)

1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
por: Seidelman, Jessica, et al.
Publicado: (2019)

Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence?
por: Gonçalves-Pereira, João, et al.
Publicado: (2011)

Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation
por: Yeoh, Siang Fei, et al.
Publicado: (2018)

821. Positive Follow-Up Blood Culture in Candidemia and Ocular Involvement
por: Iqbal, Hamail, et al.
Publicado: (2023)

Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up
por: Matsumiya, Wataru, et al.
Publicado: (2013)

Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization
por: Kamimura, Aya, et al.
Publicado: (2023)

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
por: Biagi, Mark J, et al.
Publicado: (2019)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
por: Lotfali, Ensieh, et al.
Publicado: (2022)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
por: Pérez-González, Noelia, et al.
Publicado: (2023)

Incidence and Clinical Predictors of Ocular Candidiasis in Patients with Candida Fungemia
por: Khalid, Ayesha, et al.
Publicado: (2014)

Outcomes Comparing Initial Short vs Long Course Echinocandin Therapy in Patients with Candidemia Caused by Fluconazole Susceptible Strains
por: Small-Saunders, Jennifer L, et al.
Publicado: (2017)

2117. Fluconazole vs. Echinocandins as Initial Therapy for Candidemia Caused by Fluconazole-Susceptible Species in the Era of Rapid Diagnostic Testing
por: Roshdy, Danya, et al.
Publicado: (2019)

Outcomes of Microhook ab Interno Trabeculotomy in Consecutive 36 Eyes with Uveitic Glaucoma
por: Sotani, Noriyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m1lknto7hfjdbc0kkb5npr68sb